Acuta-Capital-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
34
Total Value
86228809
Accession Number
0001104659-25-048878
Form Type
13F-HR
Manager Name
Acuta-Capital-Partners
Data Enrichment
85% identified
29 identified5 unidentified

Holdings

34 positions • $86.2M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Unicycive Therapeutics, Inc.
Shares:2.4M
Value:$1.4M
% of Portfolio:1.6% ($1.4M/$86.2M)
Jazz Pharmaceuticals plc
Shares:9.6K
Value:$1.2M
% of Portfolio:1.4% ($1.2M/$86.2M)
Verastem, Inc.
Shares:176.0K
Value:$1.1M
% of Portfolio:1.2% ($1.1M/$86.2M)
GILEAD SCIENCES, INC.
Shares:9.3K
Value:$1.0M
% of Portfolio:1.2% ($1.0M/$86.2M)
Terns Pharmaceuticals, Inc.
Shares:325.6K
Value:$898.5K
% of Portfolio:1.0% ($898.5K/$86.2M)
Zymeworks Inc.
Shares:68.5K
Value:$815.3K
% of Portfolio:0.9% ($815.3K/$86.2M)
Ultragenyx Pharmaceutical Inc.
Shares:21.3K
Value:$770.9K
% of Portfolio:0.9% ($770.9K/$86.2M)
Verve Therapeutics, Inc.
Shares:162.7K
Value:$743.6K
% of Portfolio:0.9% ($743.6K/$86.2M)
ROCKET PHARMACEUTICALS, INC.
Shares:83.3K
Value:$555.9K
% of Portfolio:0.6% ($555.9K/$86.2M)
Rapport Therapeutics, Inc.
Shares:16.4K
Value:$164.5K
% of Portfolio:0.2% ($164.5K/$86.2M)
Forte Biosciences, Inc.
Shares:18.5K
Value:$143.3K
% of Portfolio:0.2% ($143.3K/$86.2M)
Artiva Biotherapeutics, Inc.
Shares:45.5K
Value:$136.4K
% of Portfolio:0.2% ($136.4K/$86.2M)
67080N119
Shares:90.8K
Value:$17.5K
% of Portfolio:0.0% ($17.5K/$86.2M)
452CVR012
Shares:115.8K
Value:$0
% of Portfolio:0.0% ($0/$86.2M)